Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Cincinnati, Cincinnati, Ohio 45267, USA.
J Clin Endocrinol Metab. 2012 Sep;97(9):3366-74. doi: 10.1210/jc.2012-2012. Epub 2012 Jun 28.
The 20-kDa human GH (hGH) is produced in the pituitary by alternative splicing of the hGH-N gene. The 20-kDa hGH promotes growth similarly to 22-kDa or total hGH, the predominant form in circulation, but the relative effects of these isoforms on glucose metabolism have been debated.
To investigate the effect of ghrelin on 20-kDa and total hGH secretion in healthy, nonobese subjects. We also studied associations between basal GH concentration and fasting glucose and insulin as well as between dynamic GH secretion and insulin sensitivity.
Synthetic human acyl ghrelin (0.2 or 0.6 nmol/kg · h) or saline was infused in random order in 14 healthy subjects (six males, eight females; age 27.7 ± 6.3 yr; body mass index 22.0 ± 2.7 kg/m(2), mean ± SEM) on 3 separate days. Ghrelin was infused for 45 min to achieve steady-state levels and continued through a 3-h frequently sampled i.v. glucose tolerance test. Insulin sensitivity index was quantified using the minimal model of glucose kinetics.
Basal 20-kDa and total GH concentrations were 0.4 ± 0.1 and 2.2 ± 0.4 ng/ml, respectively, with a 20-kDa to total GH ratio of 0.13 ± 0.02. Females had significantly higher baseline GH levels. Ghrelin administration increased 20-kDa and total GH levels in a parallel and dose-dependent fashion, with no significant change in the ratio of the isoforms. Basal 20-kDa and total GH levels were negatively correlated with fasting glucose, insulin, and homeostasis model assessment of insulin resistance. During the frequently sampled iv glucose tolerance test, GH secretion was positively correlated with insulin sensitivity index with saline infusion.
Ghrelin dose-dependently increases endogenous 20-kDa and total GH secretion in a parallel fashion in healthy subjects. Both basal and stimulated levels of the different GH isoforms were positively associated with insulin sensitivity in this cohort of healthy men and women.
20kDa 人 GH(hGH)由 hGH-N 基因的选择性剪接在垂体中产生。20kDa hGH 与循环中主要形式 22kDa 或总 hGH 相似地促进生长,但这些同工型对葡萄糖代谢的相对影响存在争议。
研究 ghrelin 对健康、非肥胖受试者 20kDa 和总 hGH 分泌的影响。我们还研究了基础 GH 浓度与空腹血糖和胰岛素之间以及动态 GH 分泌与胰岛素敏感性之间的关系。
在 3 天内的 14 名健康受试者(6 名男性,8 名女性;年龄 27.7±6.3 岁;体重指数 22.0±2.7kg/m²,平均值±SEM)中,以随机顺序分别输注合成人酰化 ghrelin(0.2 或 0.6nmol/kg·h)或生理盐水。ghrelin 输注 45 分钟以达到稳态水平,并通过 3 小时频繁采样静脉内葡萄糖耐量试验继续输注。使用葡萄糖动力学的最小模型量化胰岛素敏感性指数。
基础 20kDa 和总 GH 浓度分别为 0.4±0.1 和 2.2±0.4ng/ml,同工型比例为 0.13±0.02。女性的基础 GH 水平显著较高。ghrelin 给药以平行且剂量依赖性的方式增加 20kDa 和总 GH 水平,同工型的比例没有显著变化。基础 20kDa 和总 GH 水平与空腹血糖、胰岛素和稳态模型评估的胰岛素抵抗呈负相关。在频繁采样的静脉内葡萄糖耐量试验期间,GH 分泌与盐水输注时的胰岛素敏感性指数呈正相关。
ghrelin 以平行的方式剂量依赖性地增加健康受试者内源性 20kDa 和总 GH 的分泌。在该队列的健康男性和女性中,不同 GH 同工型的基础和刺激水平均与胰岛素敏感性呈正相关。